
1.66 Delayed Data As of Jan 26 | ![]() Today’s Change | 1.38 Today|||52-Week Range 4.32 | +6.41% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $421.6M |
Inovio Pharmaceuticals, Inc. 660 West Germantown Pike Plymouth Meeting Pennsylvania 19462-1111 |
Jacqueline E. Shea | President, Chief Executive Officer & Director |
Peter D. Kies | Chief Financial Officer |
Kate E. Broderick | Senior Vice President-Research & Development |
Stephen Kemmerrer | Senior Vice President-Engineering Development |
Laurent M. Humeau | Chief Scientific Officer |